Overview

Study to Evaluate the Pharmacokinetics and Tolerability of Tacrolimus in Kidney Transplant Recipients.

Status:
Enrolling by invitation
Trial end date:
2021-01-10
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the pharmacokinetics and tolerability of Tacrolimus tablet(TacroBell) in kidney transplant recipients.
Phase:
Phase 4
Details
Lead Sponsor:
Chong Kun Dang Pharmaceutical
Treatments:
Tacrolimus